Search Results - "Van Vynckt, F"
-
1
α1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers
Published in The Journal of pathology (01-06-2007)“…With an overall 5 year survival rate as low as 15% for non-small cell lung cancer (NSCLC), even with surgical intervention and the use of newer molecules in…”
Get full text
Journal Article -
2
-
3
2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin- 5-yl}carbamoyl)acetamide (UNBS3157), a Novel Nonhematotoxic Naphthalimide Derivative with Potent Antitumor Activity
Published in Journal of medicinal chemistry (23-08-2007)“…Amonafide (1), a naphthalimide which binds to DNA by intercalation and poisons topoisomerase IIα, has demonstrated activity in phase II breast cancer trials,…”
Get full text
Journal Article -
4
Targeting Na + /K + -ATPase in non-small cell lung cancer (NSCLC)
Published in Journal of clinical oncology (20-06-2007)“…Abstract only 18144 Background: Non-small cell lung cancer patients that present with grade IIIB or stage IV disease have a median survival of 5–7 months if…”
Get full text
Journal Article -
5
The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers
Published in The Journal of pathology (01-06-2007)“…With an overall 5 year survival rate as low as 15% for non-small cell lung cancer (NSCLC), even with surgical intervention and the use of newer molecules in…”
Get full text
Journal Article -
6
The a I subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers
Published in The Journal of pathology (2007)Get full text
Journal Article